Elizabeth Yeu Lin
Chief Medical Officer · 5 filings · Latest: Sep 4, 2026
Tarsus Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TARS | Elizabeth Yeu Lin | Chief Medical Officer | Sep 4, 2026 | Sale | $87.50 | 13,953 | $1.2M | 1,590 | |
TARS | Lin Elizabeth Yeu | — | Sep 4, 2026 | Proposed Sale | $87.50 | 3,180 | $278.3K | — | |
TARS | Lin Elizabeth Yeu | — | Sep 4, 2026 | Proposed Sale | $87.50 | 10,773 | $942.6K | — | |
TARS | Elizabeth Yeu Lin | Chief Medical Officer | Sep 2, 2026 | Sale | $80.00 | 6,977 | $558.2K | 4,770 | |
TARS | Elizabeth Yeu Lin | Chief Medical Officer | Sep 1, 2026 | Sale | $73.86 | 4,601 | $339.8K | 18,707 | |
TARS | Lin Elizabeth Yeu | — | Sep 2, 2026 | Proposed Sale | $80.00 | 1,590 | $127.2K | — | |
TARS | Lin Elizabeth Yeu | — | Sep 2, 2026 | Proposed Sale | $80.00 | 5,387 | $431.0K | — | |
TARS | Lin Elizabeth Yeu | — | Sep 1, 2026 | Proposed Sale | $73.86 | 4,601 | $339.8K | — | |
TARS | Elizabeth Yeu Lin | Chief Medical Officer | Mar 19, 2026 | Sale | $67.00 | 390 | $26.1K | 23,308 | |
TARS | Elizabeth Yeu Lin | Chief Medical Officer | Mar 18, 2026 | Sale | $68.71 | 379 | $26.0K | 23,698 | |
TARS | Elizabeth Yeu Lin | Chief Medical Officer | Mar 17, 2026 | Sale | $69.42 | 375 | $26.0K | 24,077 | |
TARS | Lin Elizabeth Yeu | — | Mar 19, 2026 | Proposed Sale | $67.00 | 390 | $26.1K | — | |
TARS | Lin Elizabeth Yeu | — | Mar 18, 2026 | Proposed Sale | $68.71 | 379 | $26.0K | — | |
TARS | Elizabeth Yeu Lin | Chief Medical Officer | Mar 15, 2026 | Option Exercise | — | 2,511 | — | 24,452 | |
TARS | Lin Elizabeth Yeu | — | Mar 17, 2026 | Proposed Sale | $69.41 | 375 | $26.0K | — | |
TARS | Lin Elizabeth Yeu | — | Dec 16, 2025 | Proposed Sale | $79.50 | 2,078 | $165.2K | — | |
TARS | Lin Elizabeth Yeu | — | Jun 16, 2025 | Proposed Sale | $41.07 | 1,006 | $41.3K | — |